nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—peripheral nervous system neoplasm—bone cancer	0.806	1	CtDrD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—MST1R—bone cancer	0.00523	0.0709	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—MST1R—bone cancer	0.00492	0.0666	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—MST1R—bone cancer	0.00256	0.0347	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00242	0.0328	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—NR1I2—bone cancer	0.00222	0.03	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00217	0.0294	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00208	0.0282	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptors—NR1I2—bone cancer	0.00203	0.0275	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—NR1I2—bone cancer	0.00199	0.0269	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—NR1I2—bone cancer	0.00191	0.0258	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—NR1I2—bone cancer	0.00191	0.0258	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00175	0.0237	CbGpPWpGaD
Isotretinoin—RXRA—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00169	0.0229	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0016	0.0217	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00157	0.0213	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00151	0.0204	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00151	0.0204	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00142	0.0192	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00127	0.0172	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00122	0.0165	CbGpPWpGaD
Isotretinoin—RXRA—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00101	0.0137	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—NR1I2—bone cancer	0.000993	0.0135	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ZNF77—bone cancer	0.000894	0.0121	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ZNF77—bone cancer	0.000818	0.0111	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—ZNF77—bone cancer	0.000802	0.0109	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000785	0.0106	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ZNF77—bone cancer	0.000769	0.0104	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ZNF77—bone cancer	0.000769	0.0104	CbGpPWpGaD
Isotretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFA12—bone cancer	0.000689	0.00934	CbGpPWpGaD
Isotretinoin—RXRA—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000666	0.00902	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—MET—bone cancer	0.000641	0.00869	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—MET—bone cancer	0.000603	0.00817	CbGpPWpGaD
Isotretinoin—RXRA—Orphan transporters—TUBB4B—bone cancer	0.000545	0.00738	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—CDK4—bone cancer	0.000487	0.0066	CbGpPWpGaD
Isotretinoin—RXRA—Orphan transporters—TUBB2A—bone cancer	0.00047	0.00637	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000453	0.00613	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000434	0.00588	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ZNF77—bone cancer	0.00043	0.00583	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000417	0.00565	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000403	0.00546	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ZNF77—bone cancer	0.000401	0.00543	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ZNF77—bone cancer	0.000394	0.00533	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000392	0.00531	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ZNF77—bone cancer	0.000386	0.00523	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000385	0.00521	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ZNF77—bone cancer	0.00037	0.00501	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ZNF77—bone cancer	0.00037	0.00501	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000369	0.005	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—JUN—bone cancer	0.000363	0.00491	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000351	0.00475	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—JUN—bone cancer	0.000341	0.00462	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000336	0.00455	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000326	0.00442	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—bone cancer	0.000325	0.0044	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000319	0.00432	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000315	0.00426	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—MET—bone cancer	0.000314	0.00426	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000306	0.00415	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—bone cancer	0.000306	0.00414	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NR1I2—bone cancer	0.000303	0.0041	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000302	0.00409	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NR1I2—bone cancer	0.000277	0.00375	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NR1I2—bone cancer	0.000271	0.00368	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000267	0.00361	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NR1I2—bone cancer	0.00026	0.00352	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NR1I2—bone cancer	0.00026	0.00352	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000256	0.00347	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—RB1—bone cancer	0.000239	0.00323	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000226	0.00306	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—RB1—bone cancer	0.000224	0.00304	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—FUS—bone cancer	0.00021	0.00285	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—bone cancer	0.000205	0.00277	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000204	0.00277	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000198	0.00268	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ZNF77—bone cancer	0.000193	0.00261	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000192	0.00261	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—FUS—bone cancer	0.000192	0.0026	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00019	0.00257	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—FUS—bone cancer	0.000189	0.00255	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—FUS—bone cancer	0.000181	0.00245	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—FUS—bone cancer	0.000181	0.00245	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—JUN—bone cancer	0.000178	0.00241	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000175	0.00237	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP3A4—bone cancer	0.000173	0.00235	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTP1—bone cancer	0.000169	0.00229	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—TGFBR2—bone cancer	0.000169	0.00229	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000159	0.00216	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—bone cancer	0.000159	0.00216	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000157	0.00213	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTP1—bone cancer	0.000148	0.00201	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000147	0.00199	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NR1I2—bone cancer	0.000146	0.00197	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000141	0.00192	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000141	0.00191	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NR1I2—bone cancer	0.000136	0.00184	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000136	0.00184	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000133	0.00181	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NR1I2—bone cancer	0.000133	0.0018	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000133	0.0018	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NR1I2—bone cancer	0.000131	0.00177	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000128	0.00173	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NR1I2—bone cancer	0.000125	0.0017	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NR1I2—bone cancer	0.000125	0.0017	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000122	0.00166	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—RB1—bone cancer	0.000117	0.00158	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000115	0.00155	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—EIF2S1—bone cancer	0.000108	0.00146	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NDUFA12—bone cancer	0.000104	0.00141	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.0001	0.00136	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	9.89e-05	0.00134	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—EIF2S1—bone cancer	9.84e-05	0.00133	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—EIF2S1—bone cancer	9.65e-05	0.00131	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	9.61e-05	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—FUS—bone cancer	9.42e-05	0.00128	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—EZH2—bone cancer	9.35e-05	0.00127	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EIF2S1—bone cancer	9.25e-05	0.00125	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EIF2S1—bone cancer	9.25e-05	0.00125	CbGpPWpGaD
Isotretinoin—Sweating—Epirubicin—bone cancer	9.06e-05	0.000755	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—bone cancer	9.06e-05	0.000755	CcSEcCtD
Isotretinoin—Haematuria—Epirubicin—bone cancer	9.01e-05	0.000751	CcSEcCtD
Isotretinoin—Pharyngitis—Methotrexate—bone cancer	9e-05	0.00075	CcSEcCtD
Isotretinoin—Urinary tract disorder—Methotrexate—bone cancer	8.95e-05	0.000746	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—bone cancer	8.95e-05	0.000746	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—bone cancer	8.93e-05	0.000744	CcSEcCtD
Isotretinoin—Epistaxis—Epirubicin—bone cancer	8.92e-05	0.000743	CcSEcCtD
Isotretinoin—Urethral disorder—Methotrexate—bone cancer	8.89e-05	0.000741	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—bone cancer	8.87e-05	0.00074	CcSEcCtD
Isotretinoin—Sinusitis—Epirubicin—bone cancer	8.87e-05	0.000739	CcSEcCtD
Isotretinoin—Agranulocytosis—Epirubicin—bone cancer	8.82e-05	0.000735	CcSEcCtD
Isotretinoin—Pneumonia—Doxorubicin—bone cancer	8.8e-05	0.000733	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—bone cancer	8.75e-05	0.000729	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—bone cancer	8.75e-05	0.000729	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—bone cancer	8.75e-05	0.000729	CcSEcCtD
Isotretinoin—Visual impairment—Methotrexate—bone cancer	8.74e-05	0.000728	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	8.67e-05	0.000723	CcSEcCtD
Isotretinoin—Hypersensitivity—Cisplatin—bone cancer	8.65e-05	0.000721	CcSEcCtD
Isotretinoin—RXRA—Metabolism—NT5C3A—bone cancer	8.61e-05	0.00117	CbGpPWpGaD
Isotretinoin—Renal failure—Doxorubicin—bone cancer	8.6e-05	0.000717	CcSEcCtD
Isotretinoin—Erythema multiforme—Methotrexate—bone cancer	8.57e-05	0.000715	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Doxorubicin—bone cancer	8.57e-05	0.000715	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—EZH2—bone cancer	8.55e-05	0.00116	CbGpPWpGaD
Isotretinoin—Haemoglobin—Epirubicin—bone cancer	8.53e-05	0.000711	CcSEcCtD
Isotretinoin—Stomatitis—Doxorubicin—bone cancer	8.53e-05	0.000711	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—bone cancer	8.5e-05	0.000709	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—bone cancer	8.5e-05	0.000709	CcSEcCtD
Isotretinoin—Hepatitis—Epirubicin—bone cancer	8.49e-05	0.000707	CcSEcCtD
Isotretinoin—Haemorrhage—Epirubicin—bone cancer	8.49e-05	0.000707	CcSEcCtD
Isotretinoin—Eye disorder—Methotrexate—bone cancer	8.47e-05	0.000706	CcSEcCtD
Isotretinoin—Tinnitus—Methotrexate—bone cancer	8.45e-05	0.000705	CcSEcCtD
Isotretinoin—Hypoaesthesia—Epirubicin—bone cancer	8.44e-05	0.000704	CcSEcCtD
Isotretinoin—Asthenia—Cisplatin—bone cancer	8.42e-05	0.000702	CcSEcCtD
Isotretinoin—Pharyngitis—Epirubicin—bone cancer	8.42e-05	0.000702	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.42e-05	0.00114	CbGpPWpGaD
Isotretinoin—Sweating—Doxorubicin—bone cancer	8.38e-05	0.000699	CcSEcCtD
Isotretinoin—RARB—Gene Expression—EZH2—bone cancer	8.38e-05	0.00114	CbGpPWpGaD
Isotretinoin—Urinary tract disorder—Epirubicin—bone cancer	8.38e-05	0.000698	CcSEcCtD
Isotretinoin—Oedema peripheral—Epirubicin—bone cancer	8.36e-05	0.000697	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—bone cancer	8.34e-05	0.000695	CcSEcCtD
Isotretinoin—Urethral disorder—Epirubicin—bone cancer	8.32e-05	0.000693	CcSEcCtD
Isotretinoin—Epistaxis—Doxorubicin—bone cancer	8.25e-05	0.000688	CcSEcCtD
Isotretinoin—Angiopathy—Methotrexate—bone cancer	8.23e-05	0.000686	CcSEcCtD
Isotretinoin—Sinusitis—Doxorubicin—bone cancer	8.21e-05	0.000684	CcSEcCtD
Isotretinoin—Visual impairment—Epirubicin—bone cancer	8.18e-05	0.000682	CcSEcCtD
Isotretinoin—Agranulocytosis—Doxorubicin—bone cancer	8.16e-05	0.00068	CcSEcCtD
Isotretinoin—Chills—Methotrexate—bone cancer	8.14e-05	0.000678	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.07e-05	0.00109	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EZH2—bone cancer	8.04e-05	0.00109	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EZH2—bone cancer	8.04e-05	0.00109	CbGpPWpGaD
Isotretinoin—Diarrhoea—Cisplatin—bone cancer	8.03e-05	0.000669	CcSEcCtD
Isotretinoin—Erythema multiforme—Epirubicin—bone cancer	8.02e-05	0.000669	CcSEcCtD
Isotretinoin—Alopecia—Methotrexate—bone cancer	8.01e-05	0.000668	CcSEcCtD
Isotretinoin—Mental disorder—Methotrexate—bone cancer	7.94e-05	0.000662	CcSEcCtD
Isotretinoin—Eye disorder—Epirubicin—bone cancer	7.93e-05	0.000661	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—bone cancer	7.91e-05	0.000659	CcSEcCtD
Isotretinoin—Erythema—Methotrexate—bone cancer	7.89e-05	0.000658	CcSEcCtD
Isotretinoin—Malnutrition—Methotrexate—bone cancer	7.89e-05	0.000658	CcSEcCtD
Isotretinoin—Haemoglobin—Doxorubicin—bone cancer	7.89e-05	0.000658	CcSEcCtD
Isotretinoin—Flushing—Epirubicin—bone cancer	7.88e-05	0.000656	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—bone cancer	7.85e-05	0.000654	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—bone cancer	7.85e-05	0.000654	CcSEcCtD
Isotretinoin—Hypoaesthesia—Doxorubicin—bone cancer	7.81e-05	0.000651	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—bone cancer	7.79e-05	0.000649	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—bone cancer	7.75e-05	0.000646	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—bone cancer	7.73e-05	0.000645	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—bone cancer	7.7e-05	0.000642	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—bone cancer	7.7e-05	0.000641	CcSEcCtD
Isotretinoin—Back pain—Methotrexate—bone cancer	7.64e-05	0.000636	CcSEcCtD
Isotretinoin—Chills—Epirubicin—bone cancer	7.61e-05	0.000635	CcSEcCtD
Isotretinoin—Arrhythmia—Epirubicin—bone cancer	7.58e-05	0.000632	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—bone cancer	7.57e-05	0.000631	CcSEcCtD
Isotretinoin—Alopecia—Epirubicin—bone cancer	7.5e-05	0.000625	CcSEcCtD
Isotretinoin—Vomiting—Cisplatin—bone cancer	7.46e-05	0.000622	CcSEcCtD
Isotretinoin—Vision blurred—Methotrexate—bone cancer	7.44e-05	0.00062	CcSEcCtD
Isotretinoin—Mental disorder—Epirubicin—bone cancer	7.43e-05	0.00062	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—bone cancer	7.42e-05	0.000619	CcSEcCtD
Isotretinoin—Rash—Cisplatin—bone cancer	7.4e-05	0.000617	CcSEcCtD
Isotretinoin—Dermatitis—Cisplatin—bone cancer	7.4e-05	0.000616	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—bone cancer	7.39e-05	0.000616	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—bone cancer	7.39e-05	0.000616	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—bone cancer	7.34e-05	0.000612	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	7.33e-05	0.000993	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Methotrexate—bone cancer	7.32e-05	0.00061	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—bone cancer	7.32e-05	0.00061	CcSEcCtD
Isotretinoin—Anaemia—Methotrexate—bone cancer	7.3e-05	0.000608	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—bone cancer	7.29e-05	0.000607	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—bone cancer	7.28e-05	0.000607	CcSEcCtD
Isotretinoin—Tension—Epirubicin—bone cancer	7.25e-05	0.000604	CcSEcCtD
Isotretinoin—Nervousness—Epirubicin—bone cancer	7.17e-05	0.000598	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—bone cancer	7.15e-05	0.000595	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—bone cancer	7.12e-05	0.000594	CcSEcCtD
Isotretinoin—Malaise—Methotrexate—bone cancer	7.12e-05	0.000593	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	7.07e-05	0.000957	CbGpPWpGaD
Isotretinoin—Chills—Doxorubicin—bone cancer	7.04e-05	0.000587	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—bone cancer	7.01e-05	0.000585	CcSEcCtD
Isotretinoin—Nausea—Cisplatin—bone cancer	6.97e-05	0.000581	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—bone cancer	6.96e-05	0.00058	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—bone cancer	6.94e-05	0.000578	CcSEcCtD
Isotretinoin—Cough—Methotrexate—bone cancer	6.89e-05	0.000574	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—bone cancer	6.88e-05	0.000573	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—bone cancer	6.85e-05	0.000571	CcSEcCtD
Isotretinoin—Convulsion—Methotrexate—bone cancer	6.84e-05	0.00057	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—bone cancer	6.83e-05	0.00057	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—bone cancer	6.83e-05	0.00057	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—bone cancer	6.83e-05	0.000569	CcSEcCtD
Isotretinoin—Agitation—Epirubicin—bone cancer	6.79e-05	0.000566	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—bone cancer	6.74e-05	0.000561	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—bone cancer	6.72e-05	0.00056	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—bone cancer	6.72e-05	0.00056	CcSEcCtD
Isotretinoin—Arthralgia—Methotrexate—bone cancer	6.72e-05	0.00056	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—bone cancer	6.71e-05	0.000559	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	6.67e-05	0.000556	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—bone cancer	6.66e-05	0.000555	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—bone cancer	6.64e-05	0.000553	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—bone cancer	6.64e-05	0.000553	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—bone cancer	6.62e-05	0.000552	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—bone cancer	6.61e-05	0.000551	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NR1I2—bone cancer	6.53e-05	0.000884	CbGpPWpGaD
Isotretinoin—Palpitations—Epirubicin—bone cancer	6.53e-05	0.000544	CcSEcCtD
Isotretinoin—Confusional state—Methotrexate—bone cancer	6.5e-05	0.000541	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—bone cancer	6.49e-05	0.000541	CcSEcCtD
Isotretinoin—Cough—Epirubicin—bone cancer	6.45e-05	0.000537	CcSEcCtD
Isotretinoin—Anaphylactic shock—Methotrexate—bone cancer	6.44e-05	0.000537	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—bone cancer	6.44e-05	0.000537	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—bone cancer	6.4e-05	0.000533	CcSEcCtD
Isotretinoin—Infection—Methotrexate—bone cancer	6.4e-05	0.000533	CcSEcCtD
Isotretinoin—Hypertension—Epirubicin—bone cancer	6.38e-05	0.000532	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	6.37e-05	0.000863	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Doxorubicin—bone cancer	6.34e-05	0.000529	CcSEcCtD
Isotretinoin—Nervous system disorder—Methotrexate—bone cancer	6.32e-05	0.000527	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—bone cancer	6.32e-05	0.000526	CcSEcCtD
Isotretinoin—Thrombocytopenia—Methotrexate—bone cancer	6.31e-05	0.000526	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—bone cancer	6.29e-05	0.000524	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—bone cancer	6.29e-05	0.000524	CcSEcCtD
Isotretinoin—Myalgia—Epirubicin—bone cancer	6.29e-05	0.000524	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—bone cancer	6.28e-05	0.000523	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—bone cancer	6.27e-05	0.000522	CcSEcCtD
Isotretinoin—Skin disorder—Methotrexate—bone cancer	6.26e-05	0.000521	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	6.25e-05	0.000521	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—bone cancer	6.23e-05	0.000519	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—bone cancer	6.21e-05	0.000518	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—bone cancer	6.16e-05	0.000514	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—bone cancer	6.15e-05	0.000513	CcSEcCtD
Isotretinoin—Anorexia—Methotrexate—bone cancer	6.14e-05	0.000512	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—bone cancer	6.13e-05	0.000511	CcSEcCtD
Isotretinoin—Confusional state—Epirubicin—bone cancer	6.08e-05	0.000507	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—bone cancer	6.04e-05	0.000503	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—bone cancer	6.03e-05	0.000502	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—bone cancer	6.03e-05	0.000502	CcSEcCtD
Isotretinoin—Hypotension—Methotrexate—bone cancer	6.02e-05	0.000502	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—bone cancer	6.01e-05	0.000501	CcSEcCtD
Isotretinoin—Infection—Epirubicin—bone cancer	5.99e-05	0.000499	CcSEcCtD
Isotretinoin—Cough—Doxorubicin—bone cancer	5.96e-05	0.000497	CcSEcCtD
Isotretinoin—Shock—Epirubicin—bone cancer	5.93e-05	0.000494	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—bone cancer	5.92e-05	0.000494	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—bone cancer	5.91e-05	0.000493	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—bone cancer	5.9e-05	0.000492	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—bone cancer	5.9e-05	0.000492	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—bone cancer	5.88e-05	0.00049	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—bone cancer	5.87e-05	0.000489	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—bone cancer	5.86e-05	0.000488	CcSEcCtD
Isotretinoin—Hyperhidrosis—Epirubicin—bone cancer	5.83e-05	0.000486	CcSEcCtD
Isotretinoin—Insomnia—Methotrexate—bone cancer	5.83e-05	0.000486	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—bone cancer	5.82e-05	0.000485	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—bone cancer	5.82e-05	0.000485	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—bone cancer	5.82e-05	0.000485	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—bone cancer	5.8e-05	0.000483	CcSEcCtD
Isotretinoin—Paraesthesia—Methotrexate—bone cancer	5.78e-05	0.000482	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	5.78e-05	0.000482	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—bone cancer	5.75e-05	0.000479	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—bone cancer	5.75e-05	0.000479	CcSEcCtD
Isotretinoin—Dyspnoea—Methotrexate—bone cancer	5.74e-05	0.000479	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—bone cancer	5.73e-05	0.000477	CcSEcCtD
Isotretinoin—Dry mouth—Doxorubicin—bone cancer	5.69e-05	0.000474	CcSEcCtD
Isotretinoin—Dyspepsia—Methotrexate—bone cancer	5.67e-05	0.000473	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—bone cancer	5.63e-05	0.000469	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—bone cancer	5.62e-05	0.000469	CcSEcCtD
Isotretinoin—Decreased appetite—Methotrexate—bone cancer	5.6e-05	0.000467	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—bone cancer	5.58e-05	0.000465	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—bone cancer	5.58e-05	0.000465	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Methotrexate—bone cancer	5.56e-05	0.000464	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—bone cancer	5.55e-05	0.000463	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—bone cancer	5.54e-05	0.000462	CcSEcCtD
Isotretinoin—Pain—Methotrexate—bone cancer	5.51e-05	0.000459	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—bone cancer	5.49e-05	0.000458	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—bone cancer	5.49e-05	0.000457	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—bone cancer	5.47e-05	0.000456	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—bone cancer	5.46e-05	0.000455	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—bone cancer	5.45e-05	0.000454	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—bone cancer	5.44e-05	0.000454	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—bone cancer	5.42e-05	0.000452	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—bone cancer	5.41e-05	0.000451	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—bone cancer	5.39e-05	0.000449	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—bone cancer	5.37e-05	0.000448	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—bone cancer	5.36e-05	0.000447	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—bone cancer	5.32e-05	0.000443	CcSEcCtD
Isotretinoin—Feeling abnormal—Methotrexate—bone cancer	5.31e-05	0.000442	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—bone cancer	5.31e-05	0.000442	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Methotrexate—bone cancer	5.27e-05	0.000439	CcSEcCtD
Isotretinoin—Decreased appetite—Epirubicin—bone cancer	5.24e-05	0.000437	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—bone cancer	5.21e-05	0.000434	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—bone cancer	5.2e-05	0.000434	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—bone cancer	5.2e-05	0.000433	CcSEcCtD
Isotretinoin—Pain—Epirubicin—bone cancer	5.16e-05	0.00043	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—bone cancer	5.16e-05	0.00043	CcSEcCtD
Isotretinoin—Urticaria—Methotrexate—bone cancer	5.12e-05	0.000427	CcSEcCtD
Isotretinoin—Abdominal pain—Methotrexate—bone cancer	5.09e-05	0.000424	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—bone cancer	5.09e-05	0.000424	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—bone cancer	5.08e-05	0.000424	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—bone cancer	5.05e-05	0.00042	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	5.01e-05	0.000679	CbGpPWpGaD
Isotretinoin—Paraesthesia—Doxorubicin—bone cancer	5.01e-05	0.000417	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—bone cancer	4.97e-05	0.000414	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—bone cancer	4.97e-05	0.000414	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—bone cancer	4.96e-05	0.000413	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Epirubicin—bone cancer	4.93e-05	0.000411	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—bone cancer	4.91e-05	0.000409	CcSEcCtD
Isotretinoin—Decreased appetite—Doxorubicin—bone cancer	4.85e-05	0.000404	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—EIF2S1—bone cancer	4.82e-05	0.000653	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—bone cancer	4.82e-05	0.000401	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—bone cancer	4.81e-05	0.000401	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—bone cancer	4.79e-05	0.000399	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—bone cancer	4.77e-05	0.000398	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—bone cancer	4.77e-05	0.000398	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—bone cancer	4.77e-05	0.000397	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—bone cancer	4.77e-05	0.000397	CcSEcCtD
Isotretinoin—Hypersensitivity—Methotrexate—bone cancer	4.75e-05	0.000396	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MET—bone cancer	4.62e-05	0.000626	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CDK4—bone cancer	4.62e-05	0.000626	CbGpPWpGaD
Isotretinoin—Asthenia—Methotrexate—bone cancer	4.62e-05	0.000385	CcSEcCtD
Isotretinoin—Feeling abnormal—Doxorubicin—bone cancer	4.6e-05	0.000383	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Doxorubicin—bone cancer	4.56e-05	0.00038	CcSEcCtD
Isotretinoin—Pruritus—Methotrexate—bone cancer	4.56e-05	0.00038	CcSEcCtD
Isotretinoin—Hypersensitivity—Epirubicin—bone cancer	4.44e-05	0.00037	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—bone cancer	4.43e-05	0.000369	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—bone cancer	4.41e-05	0.000368	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—bone cancer	4.41e-05	0.000368	CcSEcCtD
Isotretinoin—Diarrhoea—Methotrexate—bone cancer	4.41e-05	0.000367	CcSEcCtD
Isotretinoin—Asthenia—Epirubicin—bone cancer	4.33e-05	0.00036	CcSEcCtD
Isotretinoin—Pruritus—Epirubicin—bone cancer	4.27e-05	0.000355	CcSEcCtD
Isotretinoin—Dizziness—Methotrexate—bone cancer	4.26e-05	0.000355	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.21e-05	0.00057	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EZH2—bone cancer	4.19e-05	0.000567	CbGpPWpGaD
Isotretinoin—Diarrhoea—Epirubicin—bone cancer	4.12e-05	0.000344	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—bone cancer	4.11e-05	0.000343	CcSEcCtD
Isotretinoin—Vomiting—Methotrexate—bone cancer	4.1e-05	0.000341	CcSEcCtD
Isotretinoin—Rash—Methotrexate—bone cancer	4.06e-05	0.000339	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—bone cancer	4.06e-05	0.000338	CcSEcCtD
Isotretinoin—Headache—Methotrexate—bone cancer	4.04e-05	0.000336	CcSEcCtD
Isotretinoin—Asthenia—Doxorubicin—bone cancer	4e-05	0.000334	CcSEcCtD
Isotretinoin—Dizziness—Epirubicin—bone cancer	3.99e-05	0.000332	CcSEcCtD
Isotretinoin—Pruritus—Doxorubicin—bone cancer	3.95e-05	0.000329	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MMP2—bone cancer	3.86e-05	0.000522	CbGpPWpGaD
Isotretinoin—Vomiting—Epirubicin—bone cancer	3.83e-05	0.000319	CcSEcCtD
Isotretinoin—Nausea—Methotrexate—bone cancer	3.83e-05	0.000319	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—bone cancer	3.82e-05	0.000318	CcSEcCtD
Isotretinoin—Rash—Epirubicin—bone cancer	3.8e-05	0.000317	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—bone cancer	3.8e-05	0.000317	CcSEcCtD
Isotretinoin—Headache—Epirubicin—bone cancer	3.78e-05	0.000315	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ENO2—bone cancer	3.77e-05	0.000511	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—bone cancer	3.69e-05	0.000307	CcSEcCtD
Isotretinoin—Nausea—Epirubicin—bone cancer	3.58e-05	0.000298	CcSEcCtD
Isotretinoin—Vomiting—Doxorubicin—bone cancer	3.55e-05	0.000296	CcSEcCtD
Isotretinoin—Rash—Doxorubicin—bone cancer	3.52e-05	0.000293	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—bone cancer	3.51e-05	0.000293	CcSEcCtD
Isotretinoin—RXRA—Metabolism—DHFR—bone cancer	3.5e-05	0.000474	CbGpPWpGaD
Isotretinoin—Headache—Doxorubicin—bone cancer	3.49e-05	0.000291	CcSEcCtD
Isotretinoin—Nausea—Doxorubicin—bone cancer	3.31e-05	0.000276	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GNA11—bone cancer	3.27e-05	0.000443	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP3A4—bone cancer	2.97e-05	0.000402	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.95e-05	0.0004	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—bone cancer	2.9e-05	0.000393	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTP1—bone cancer	2.54e-05	0.000344	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—bone cancer	2.34e-05	0.000317	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—bone cancer	1.31e-05	0.000178	CbGpPWpGaD
